MerLion Announces Initiation of a Phase III Clinical Programme to evaluate Finafloxacin
Singapore, 18th April, 2012 – MerLion Pharmaceuticals Pte Ltd (MerLion) announces
the start of the first Phase III clinical trial to evaluate finafloxacin for treating infections
of the ear.
MerLion Announces Initiation of a Phase III Clinical Programme to evaluate Finafloxacin Read More »